Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07094971 · ClinicalTrials.gov registry record · NA

Pure Impact Treatment to Strengthen and Tone Abdomen, Quadriceps and Glutes Muscles

A NA study of Muscle Strength and Muscle Tone, sponsored by Sofwave Medical.

Recruiting
Registry status
NA
Development phase
44
Enrollment target
1
Study location

NCT07094971: Recruiting NA study of Muscle Strength and Muscle Tone, sponsored by Sofwave Medical.

NCT07094971 is a NA study of Muscle Strength and Muscle Tone that is actively recruiting participants, run by Sofwave Medical. The registered enrollment target is 44 participants, roughly in line with the 44-participant average among 6 other Muscle Strength trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07094971, a NA study of Muscle Strength and Muscle Tone, is actively recruiting participants, sponsored by Sofwave Medical.

RECRUITING
Registry status
NA
Development phase
44 participants
Enrollment target
1
Study location

Study Summary

Open-label, non-randomized, prospective, single-center, self-controlled clinical study.

Primary Outcome

Higher improvement rate of the muscles strength tests at the test group compared to the control group using series of exercises tests including questionnaire, and a functional evaluation of the muscles of the abdomen, quadriceps, and glutes.

Interventions

  • DEVICE Pure Impact

Study Locations (1)

Oregon

  • Movassaghi Plastic Surgery & Ziba Medical Spa - Eugene

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2025-07-11
Est. Completion 2026-07-10
Phase NA
Sofwave Medical

12 total trials

What NCT07094971 shows while recruiting

NCT07094971 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, roughly in line with the 44-participant average among 6 other Muscle Strength trials with a reported enrollment target.

The record links to 2 conditions, with Muscle Strength appearing as the primary indexed condition, and to 1 intervention - of which Pure Impact is the first listed.

NCT07094971 reports a single indexed study location in Oregon.

Frequently Asked Questions

What is clinical trial NCT07094971 about?

NCT07094971 is a clinical study titled "Pure Impact Treatment to Strengthen and Tone Abdomen, Quadriceps and Glutes Muscles". Open-label, non-randomized, prospective, single-center, self-controlled clinical study.

What is the current status of trial NCT07094971?

This trial is currently recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2025-07-11. Estimated completion is 2026-07-10.

What conditions does trial NCT07094971 study?

This clinical trial studies the following conditions: Muscle Strength, Muscle Tone.

What interventions are being tested in trial NCT07094971?

The interventions under investigation include: Pure Impact (DEVICE).

Who is sponsoring clinical trial NCT07094971?

This trial is sponsored by Sofwave Medical, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07094971 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Muscle Strength

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02323945 · 44 participants · NA

    Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury

  • NCT03093909 · 44 participants · Phase 1

    Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

  • NCT03104491 · 44 participants · Phase 1

    Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

  • NCT03781765 · 44 participants · Phase 4

    Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07094971, the US trial registry maintained by the National Library of Medicine. NCT07094971 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.